Aviado · Research
Longevity Daily
Friday, May 8, 2026
Listen
Today's Brief
Today's strongest theme is evidence-based optimism — with some important reality checks. The must-read is a landmark study of 11,287 older adults showing that four lifestyle behaviors can deliver a 40% reduction in combined risk of death, dementia, and disability — even when you start in your 70s. Elsewhere, a Washington Post expert guide identifies the one brain supplement with actual clinical trial evidence for slowing cognitive aging, a counterintuitive new finding challenges the omega-3-for-brainpower consensus, and Aviado Research breaks down why sage extract is producing LDL results that rival statins.
10 stories1 peer-reviewed1 trials1 Aviado original
Cognitive Health & Neuroprotection
Brain Health Supplements Are Booming — Here's What Actually Works, According to One Longevity Expert
The brain supplement market generates billions annually, but most products have zero clinical trial support. UCLA longevity expert Gary Small singles out one compound — backed by human RCT data — that has demonstrated a roughly two-year slowdown in cognitive aging, a bar most competitors can't touch. If you're spending money on brain pills, this Washington Post breakdown is the benchmark your stack needs.
Read more →Brain Performance Can Measurably Improve at Any Age — Including Well Into Your 90s
A study tracking adults from 19 to 94 found that consistent 'micro-training' — brief, repeated cognitive sessions — produced measurable improvements in brain performance across every age group. The key word is consistent: sporadic intensive effort doesn't produce the same result. This directly challenges the assumption that cognitive decline is locked in by aging biology.
Read more →Omega-3 Supplement Users Showed Faster Cognitive Decline Than Non-Users in New Analysis
A new study found that people self-reporting omega-3 supplement use performed worse on multiple standard memory and thinking tests over time compared to non-users — the opposite of what most consumers expect. Reverse causation is a real possibility here (sicker people may be more likely to take supplements), and this appears to be observational data, not an RCT. Still, it's a pointed reminder that the evidence base for omega-3s and cognition is considerably murkier than supplement marketing suggests.
Read more →Supplements & Compounds
Sage Extract Cuts LDL by 35% in Three Months — But the Blood Sugar Effect Depends on Your Metabolic Profile
New clinical data shows that 500mg of standardized Salvia officinalis extract twice daily can slash LDL cholesterol by over a third in just 12 weeks — a magnitude of effect most people associate only with statins or prescription drugs. The catch: blood sugar responses are highly variable, with strong responders clustered among people who have insulin resistance or type 2 diabetes while others see little effect. Aviado Research breaks down the optimal dosing, who is most likely to respond, and what to track so you're not flying blind.
Read the full Aviado analysis →Vitamin B12 May Improve Muscle Mitochondrial Function in Aging — Beyond Its Known Roles
Researchers at the University of Alabama at Birmingham found that B12 supplementation in aged mice significantly restored muscle mitochondrial function — a mechanism almost entirely absent from prior B12 research, which has focused on anemia and neuropathy. This is a mouse study, so direct human extrapolation requires caution. That said, adults over 50 absorb dietary B12 less efficiently and are routinely deficient, making this a population with potentially the most to gain if the effect translates.
Read more →Research & Papers
Lifelong Obesity Starves the Aging Brain of Oxygen — And Your Past Weight Matters as Much as Today's
A GeroScience study tracking 303 community-dwelling adults found that both current and historical body-weight patterns directly reduce the brain's cerebral metabolic rate of oxygen (CMRO₂), essentially depriving aging brain tissue of the fuel it needs to function. The finding is significant because it implicates your weight history — not just present-day BMI — in brain aging trajectories. This makes the case for maintaining healthy weight across the lifespan, not only in later years.
Read more →Metformin Works in the Gut, Not the Liver — A Finding That Rewrites Its Mechanism of Action
New research reveals that metformin's primary glucose-lowering effect operates in intestinal cells — not the liver, as long assumed — by slowing mitochondrial energy production and forcing the gut to metabolize more circulating sugar. This reframes the pharmacology of one of the world's most widely prescribed drugs and may explain why individual responses vary significantly. For anyone following metformin's potential as a longevity compound, this mechanistic revision adds important context.
Read more →Lifestyle & Nutrition
Four Lifestyle Behaviors Deliver a 10% Healthspan Gain in Older Adults — Even When You Start in Your 70s
Australian researchers followed 11,287 healthy adults (median age 74) for 6.6 years and found that adhering to four behaviors — Mediterranean diet, moderate physical activity, non-smoking, and moderate alcohol consumption — was associated with a hazard ratio of 0.60 for the composite endpoint of death, dementia, and persistent physical disability: a 40% reduction in risk compared to an unfavorable lifestyle. A favorable lifestyle was also prospectively linked to a 10% gain in disability-free years and a compression of morbidity. Crucially, the effect held regardless of age, sex, BMI, diabetes status, and hypertension. This is the most rigorous evidence yet that lifestyle habits deliver outsized returns even when adopted late — making it the must-read of today's digest.
Read more →The Longevity Secrets Helping Elite Athletes Blow Past the Limits of Age
The New York Times Magazine profiles elite athletes competing and thriving well beyond conventional retirement age, and the training adaptations, recovery strategies, and mindset shifts making it possible. While elite performance is not the goal for most readers, the interventions these athletes use increasingly overlap with what longevity researchers recommend more broadly. Worth reading as a window into the outer edge of what human aging can look like.
Read more →Industry & Policy
University of Arizona Launches Phase 3 Rapamycin Trial to Test Immune Resilience in Older Adults
Researchers at the University of Arizona are beginning a double-blind, randomized Phase 3 trial testing whether rapamycin — the mTOR inhibitor long studied by longevity researchers — can improve immune resilience in older adults. This is a significant step up from earlier exploratory work: a full Phase 3 design means any positive results will carry genuine regulatory and clinical weight. For those watching rapamycin's path toward mainstream longevity validation, this is a landmark trial to follow.
Read more →